Retinal Vein Occlusion
📧 Sign up to get email alerts when something new happens for Retinal Vein Occlusion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Retrospective Analysis of the Clinical Characteristics of Retinal Vein Occlusion
This is a completed retrospective analysis describing the clinical characteristics of retinal vein occlusion. The study is sponsored by Zhon…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO [Phase 2]
Phase 2 study evaluating the usability of the SB11 prefilled syringe in subjects with wet age-related macular degeneration or macular edema …
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion [Phase 2]
A Phase 2 safety and proof-of-concept study of ANXV (Annexin A5) in retinal vein occlusion has been completed, reporting collected safety an…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion
This ClinicalTrials.gov entry reports on a completed study measuring vitreous levels of tumor necrosis factor-alpha in patients with retinal…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients [Phase 2, Phase 3]
Clinical trial update evaluating the efficacy of Faricimab for age-related macular degeneration, diabetic macular edema, and retinal vein oc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO
This clinical trial update describes the use of DARWEN, an artificial intelligence technology, for eye disorders. It investigates factors in…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 3]
A Phase 3 study comparing KSI-301 with aflibercept in macular edema due to retinal vein occlusion has completed. Results were posted in June…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating intravitreal bevacizumab (Avastin) for diabetic retinopathy and retinal vein occlusion; the study was te…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
A completed clinical trial evaluating hybrid deep learning algorithms to detect eye diseases from fundus images. The study targeted conditio…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China [Phase 4]
Phase 4 clinical trial evaluating OZURDEX in macular edema due to retinal vein occlusion in China has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections [Phase 4]
Phase 4 trial update on DEXTENZA for pain and inflammation in patients receiving intravitreal anti-VEGF injections; study terminated.
-
FDA approval · 2022-08-02FDA Approved: CIMERLI — Original Application (Coherus BioSciences Inc)
FDA approved CIMERLI (ranibizumab-eqrn) from Coherus as an original Biologics License Application. It is a biosimilar to ranibizumab (Lucent…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: SD-OCT Angiography [NA]
Clinical trial update for SD-OCT Angiography study (NCT02510885) sponsored by Duke University; the trial is terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Minocycline to Treat Branch Retinal Vein Occlusion [Phase 1, Phase 2]
A post-completion update on a Phase 1/2 trial assessing minocycline for retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 2]
Phase 2 trial of TLC399 (ProDex) in macular edema due to retinal vein occlusion completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept [Phase 4]
Phase 4 trial update exploring cytokine and visual outcomes in eyes treated with aflibercept for age-related macular degeneration and diabet…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab [Phase 4]
Phase 4 trial exploring how cytokine changes relate to visual outcomes in eyes treated with ranibizumab for macular diseases.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO [Phase 3]
Phase 3 trial of suprachoroidal triamcinolone acetonide with IVT anti-VEGF for macular edema after retinal vein occlusion was terminated; re…
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO [Phase 3]
Phase 3 trial evaluating suprachoroidal triamcinolone acetonide with IVT aflibercept for macular edema after retinal vein occlusion was term…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Minocycline to Treat Central Retinal Vein Occlusion [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating minocycline for central retinal vein occlusion (retinal vein occlusion).
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO [Phase 2]
Phase 2 trial evaluating suprachoroidal triamcinolone acetonide with IVT aflibercept for macular edema after retinal vein occlusion has comp…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema [NA]
Exploratory study of KPI-121 on intra- or subretinal fluid due to retinal vein occlusion and diabetic macular edema has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium [Phase 4]
A Phase 4 extension study assessing the effect of Macugen on the corneal endothelium has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO [Phase 4]
Phase 4 trial update assessing peripheral and macular retinal vascular perfusion and leakage in diabetic macular edema and retinal vein occl…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. [Phase 2]
Phase 2 trial evaluating dorzolamide-timolol drops administered with injections for wet AMD, age-related macular degeneration, diabetic macu…